
Opinion|Videos|July 3, 2024
Investigational Therapies Paving New PNH Treatment Pathways
Dr Haumschild continues leading a discussion surrounding potential treatment advancements in the PNH landscape.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other complement-driven rare diseases, particularly in relation to investigational therapeutics targeting the alternative pathway?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Orca-T Gains FDA Approval for Matched Donor Stem Cell Transplant
2
Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS
3
Racial Gaps in Cancer Pain Management Persist in Community Care: Ila Sruti, MPH
4
House Panel Advances Bills to Expand Veterans’ Health Care Access
5





